Literature DB >> 11302190

Apoptosis-inducing activity of high molecular weight fractions of tea extracts.

S Hayakawa1, T Kimura, K Saeki, Y Koyama, Y Aoyagi, T Noro, Y Nakamura, M Isemura.   

Abstract

High molecular weight fractions of green tea, black tea, oolong tea, and pu-erh tea were found to induce apoptosis in human monoblastic leukemia U937 cells by examination of their ability to inhibit cell proliferation and to induce apoptotic body formation and DNA ladder formation. These tea fractions were also shown to induce apoptosis in stomach cancer MKN-45 cells. In addition to known antitumor-promoting activity of tea high molecular weight fractions, their apoptosis-inducing activity may contribute to cancer chemopreventive effects of tea.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302190     DOI: 10.1271/bbb.65.459

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  5 in total

1.  Effect of black tea aqueous non-dialysate onHelicobacter pylori infection in Mongolian gerbils.

Authors:  Fumiyo Takabayashi; Yoshiyuki Nakamura; Noboru Harada
Journal:  Environ Health Prev Med       Date:  2004-07       Impact factor: 3.674

Review 2.  Health-promoting effects of green tea.

Authors:  Yasuo Suzuki; Noriyuki Miyoshi; Mamoru Isemura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

3.  Pu-erh tea inhibits tumor cell growth by down-regulating mutant p53.

Authors:  Lanjun Zhao; Shuting Jia; Wenru Tang; Jun Sheng; Ying Luo
Journal:  Int J Mol Sci       Date:  2011-11-07       Impact factor: 5.923

4.  Pu-Erh tea and GABA attenuates oxidative stress in kainic acid-induced status epilepticus.

Authors:  Chien-Wei Hou
Journal:  J Biomed Sci       Date:  2011-10-20       Impact factor: 8.410

5.  Pu-erh Tea Water Extract Mediates Cell Cycle Arrest and Apoptosis in MDA-MB-231 Human Breast Cancer Cells.

Authors:  Jing Xie; Haishuang Yu; Shuang Song; Chongye Fang; Xuanjun Wang; Zhongbin Bai; Xiao Ma; Shumei Hao; Hong-Ye Zhao; Jun Sheng
Journal:  Front Pharmacol       Date:  2017-04-06       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.